Bottom line
HELX vs HRTS: the short answer
HELX (Franklin Genomic Advancements ETF) and HRTS (Tema Heart & Health ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
HELX is cheaper at 0.5% vs 0.75% — a difference of $25 a year per $10,000 invested.
Over one year, HELX returned +25.9% vs +23.6% for HRTS.
Updated Nov 19, 2026
HELX vs HRTS side by side
| HELX | HRTS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Franklin Templeton | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.5% | 0.75% |
| Annual cost per $10k | $50 | $75 |
| 10-yr cost on $10k (prospectus) | $629 | $1,168 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +25.9% | +23.6% |
| 5-yr return (annualized) | −3.8% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +19.6% | +15.8% |
| Worst quarter | −23.7% | −12.4% |
| Net assets (fund) | $27.9M | $51.9M |
| Number of holdings | 63 | 45 |
| Portfolio turnover | 29% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HELX | HRTS | Difference |
|---|---|---|---|
| 2025 | +25.9% | +23.6% | +2.3% |
| 2024 | −5.1% | +3.6% | −8.7% |
Source: Fund prospectus bar charts
Holdings overlap
5 of HELX's top 25 holdings also appear in HRTS's top 25.
| Holding | HELX | HRTS |
|---|---|---|
| Bridgebio Pharma Inc | 3.50% | 2.59% |
| Eli Lilly & Company | 2.95% | 11.52% |
| Vertex Pharmaceuticals Inc | 2.75% | 2.93% |
| Astrazeneca Plc | 2.70% | 4.00% |
| Regeneron Pharmaceuticals Inc | 1.80% | 1.67% |
Source: SEC Form N-PORT
HELX top 10
- Guardant Health Inc — 9.09%
- Natera Inc — 7.46%
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- Adaptive Biotechnologies Corp — 3.99%
- United Therapeutics Corp — 3.51%
- Bridgebio Pharma Inc — 3.50%
- Eli Lilly & Company — 2.95%
- Twist Bioscience Corp — 2.85%
- Vertex Pharmaceuticals Inc — 2.75%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between HELX and HRTS?
Which is cheaper, HELX or HRTS?
Should I own both HELX and HRTS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.